Dr. Natasha B. Hunter, MD

  • Seattle, WA
  • Medical oncologist
NPI1669733572PAC ID1052622511
Medicare services, 2024
253
Medicare patients, 2024
115
Part D claims, 2024
182
Clinical trials
1
MIPS score, 2024
94
Practice address
825 Eastlake Avenue East, Seattle, WA 98109
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Fred Hutchinson Cancer Center

Hospital · Seattle, Washington

Find Dr. Hunter's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Natasha B. Hunter is a medical oncologist in Seattle, Washington

Dr. Hunter practices at Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center.

Dr. Hunter's NPI, 1669733572, was assigned on June 6, 2012. Dr. Hunter holds Washington license MD60861206.

NPI and contact details
Medicare PAC ID
1052622511
NPI enumeration date
June 6, 2012
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
40
Medical school graduation
2012

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Natasha B. Hunter practices at Fred Hutchinson Cancer Center in Seattle, Washington

Dr. Hunter's primary practice is Fred Hutchinson Cancer Center, at 825 Eastlake Avenue East, Seattle, WA 98109.

Source: Dmand AI Affiliation Data

Dr. Natasha B. Hunter is affiliated with 2 sites of care and 1 medical group

Dr. Hunter's primary practice is Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center. Dr. Hunter is also affiliated with UW Medical Center - Montlake. The medical group on file is UW Physicians.

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Natasha B. Hunter's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hunter practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Fred Hutchinson Cancer CenterAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Hunter practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Fred Hutchinson Cancer Center and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Natasha B. Hunter is one of 145 medical oncologists in Washington

Medical oncology is Dr. Hunter's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Hunter is licensed in Washington.

Specialties and state licenses

  • Medical oncology, WashingtonPrimaryLicense MD60861206 · taxonomy 207RX0202X

Medical oncologists near Dr. Hunter

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Natasha B. Hunter billed Medicare for 253 services in 2024

CMS data shows 253 Medicare services from Dr. Hunter across 4 procedure codes in 2024, for 115 Medicare patients. Medicare paid $22,119 for them. Every service was in an office.

Medicare services, 2024253
Medicare patients115
Paid by Medicare$22,119
Procedure codes4

Dr. Hunter's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 2422024: 19320%
Other services
2023: 02024: 60

Dr. Hunter compared with the Washington median for medical oncologists, 2024

  • Dr. Hunter
  • Washington median
Medicare services
253vs 36230% below
Medicare patients
115vs 13917% below
Part D claims
63vs 18065% below

Medians across 131 medical oncologists in Washington with Dmand AI profiles that report each measure.

Dr. Hunter's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Hunter

Need commercial claims for Dr. Hunter?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Hunter and other medical oncologists in Washington.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Natasha B. Hunter treated 115 Medicare patients in 2024, average age 73

CMS counts 115 Medicare patients who saw Dr. Hunter in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have cancer, and 67% have high cholesterol. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hunter's median patient age at 61, with 96% women.

Medicare patients, 2024115
Average age73
Average risk score1.34

Dr. Hunter's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Chronic conditions among Dr. Hunter's Medicare patients, 2024

  1. Cancer75%
  2. High cholesterol67%
  3. High blood pressure53%
  4. Arthritis45%
  5. Anxiety29%
  6. Osteoporosis25%
  7. Mood disorders24%
  8. Depression23%

Share of Medicare patients with each condition. A patient can have several.

Dr. Hunter's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 61

Patient panel by sex, all payers

  • Women96%
  • Men3%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Natasha B. Hunter wrote 182 Medicare Part D claims in 2024

In 2024, Dr. Hunter wrote 182 Medicare Part D claims for 56 patients. 90% of them were for generic drugs. CMS names the drug for 63 of them, across 2 drugs with 11 or more claims each, at $1,539 in total drug cost. In 2023, CMS named 71 claims across 2 drugs.

Part D claims, 2024182
Drugs named by CMS2
Total drug cost$1,539
Part D patients56

Dr. Hunter's Part D claims by kind of drug, 2024

  • Generic164 claims90%
  • Brand-name18 claims10%

Dr. Hunter's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Hunter's Part D claims, 2024

  • Opioids7%12 of 182 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 712024: 6311%

Drugs named by CMS: 2 in 2024, 2 in 2023.

See all prescribing by Dr. Hunter

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Natasha B. Hunter scored 94 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Hunter for performance year 2024, reported through an alternative payment model (APM). Dr. Hunter accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hunter as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Hunter's MIPS scores, performance year 2024

  • 94of 100Final score
  • 74.6of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Hunter by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Natasha B. Hunter has worked on 1 clinical trial

Dmand AI links Dr. Hunter to 1 clinical trial. Conditions studied include Breast Neoplasms and Breast Diseases. Open Payments lists research payments to Dr. Hunter that name 1 trial.

Conditions in Dr. Hunter's trials

  • Breast Neoplasms
  • Breast Diseases

Investigators on the most trials with Dr. Hunter

Recent clinical trials with Dr. Hunter

Sources: Open Payments (CMS), 2025 data, released July 7, 2026; ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage

Dr. Natasha B. Hunter received $2,945 in industry payments from 2019 to 2025

CMS Open Payments shows 13 general payments to Dr. Hunter from 7 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 72% of the total. Novartis Pharmaceuticals Corporation paid the most, $2,115. It also lists 1 research payment totaling $10,130 in 2022, naming 1 clinical trial.

General payments to Dr. Hunter by program year, 2019 to 2025

General payments to Dr. Hunter by kind, 2019 to 2025

$2.9Kin total
  • Consulting fees$2,11572%
  • Food and beverage$81828%
  • Education$120%

Companies that paid Dr. Hunter the most, 2019 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Hunter

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Dr. Natasha B. Hunter's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Clinical trials and co-investigatorsClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Natasha B. Hunter

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Natasha B. Hunter's NPI number?

Dr. Natasha B. Hunter's NPI number is 1669733572. It was assigned on June 6, 2012, and it is active in the NPI Registry.

What kind of doctor is Dr. Natasha B. Hunter?

Dr. Natasha B. Hunter is a medical oncologist in Seattle, Washington. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Natasha B. Hunter practice?

Dr. Hunter practices at 825 Eastlake Avenue East, Seattle, WA 98109. Dr. Hunter's primary practice is Fred Hutchinson Cancer Center in Seattle, Washington, part of Fred Hutchinson Cancer Center.

What is Dr. Natasha B. Hunter's medical license number?

Dr. Hunter holds Washington license MD60861206.

Which hospitals is Dr. Natasha B. Hunter affiliated with?

Dr. Hunter practices at Fred Hutchinson Cancer Center in Seattle, Washington. Dr. Hunter is also affiliated with UW Medical Center - Montlake.

What medical group is Dr. Natasha B. Hunter part of?

Dr. Hunter is linked to UW Physicians.

Does Dr. Natasha B. Hunter accept Medicare?

Yes. CMS data shows Dr. Hunter billed Medicare for 253 services in 2024, and Dr. Hunter accepts Medicare assignment.

Does Dr. Natasha B. Hunter offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Hunter as offering telehealth services.

What is Dr. Natasha B. Hunter's MIPS score?

Dr. Hunter's MIPS final score for performance year 2024 is 94 out of 100, reported through an alternative payment model (APM).

How many Medicare patients does Dr. Natasha B. Hunter see?

CMS counts 115 Medicare patients who saw Dr. Hunter in 2024, with an average age of 73.

Show 5 more questionsShow fewer questions

What services does Dr. Natasha B. Hunter bill to Medicare?

In 2024, Dr. Hunter's most billed Medicare services were office visit, established patient (99215), medicare service (G2211) and office visit, established patient (99214).

What drugs does Dr. Natasha B. Hunter prescribe most?

In 2024 Medicare Part D data, Dr. Hunter's most prescribed drugs by claims were Letrozole and Anastrozole.

Has Dr. Natasha B. Hunter received payments from drug or device companies?

CMS Open Payments shows $2,945 in general payments to Dr. Hunter from 7 companies from 2019 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.

How long has Dr. Natasha B. Hunter been practicing?

Dr. Hunter graduated from medical school in 2012, 14 years ago.

Does Dr. Natasha B. Hunter do research?

Dr. Hunter has worked on 1 clinical trial.

Selling to medical oncology practices?

See medical oncologists in Washington by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)